What Is DSIP (Delta Sleep-Inducing Peptide)?

DSIP (delta sleep-inducing peptide) is a naturally occurring nine-amino-acid peptide that was first isolated from rabbit brain tissue in 1977 and named for its ability to promote slow-wave, delta-wave sleep in animals. It has since been studied for sleep, pain, and stress-related effects, but it is not FDA-approved for human use and the human evidence remains small and inconsistent.

This article covers what DSIP is, what the research actually shows, how it is typically studied, and what US buyers should know about its legal status.

What DSIP Is and Where It Comes From

DSIP is a nonapeptide — a chain of nine amino acids — with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It was identified by researchers Guido Schoenenberger and Marcel Monnier, who were searching for a naturally occurring substance that could trigger sleep.

• Class: regulatory peptide and neuromodulator, not a classic neurotransmitter
• Length: nine amino acids, roughly 687 Da
• Where it is found: hypothalamus, pituitary, peripheral tissues, blood, and milk
• Half-life: only a few minutes in circulation before enzymes break it down

DSIP is a naturally occurring peptide found in the mammalian brain, not a synthetic compound invented in a lab. That said, being natural says nothing about whether a peptide is safe or effective as a drug.

What Research Says About DSIP

Most DSIP research comes from animal studies and a handful of small human trials conducted in the 1970s and 1980s. Results have been mixed, and the effect appears to depend heavily on dose — low doses were sometimes reported to induce sleep, while higher doses seemed to do the opposite.

No large, modern, placebo-controlled trial has shown that DSIP reliably treats insomnia or any other condition in humans. Anyone claiming DSIP is a proven sleep treatment is going beyond what the published data support.

How DSIP Is Used in Research and Reported Protocols

Early human studies gave DSIP intravenously at roughly 25–50 nmol/kg, which works out to about 1–3 mg for an average adult. Online vendors and forums often describe much smaller subcutaneous doses in the 100–300 mcg range, but those numbers come from community practice, not clinical data.

Reconstitution matters as much as the route, since the diluent determines concentration. A common question in peptide research is bac water what is it, because bacteriostatic water contains benzyl alcohol that extends shelf life but is not appropriate for every use. Lyophilized vials should also be stored cold and protected from light.

DSIP vs. Other Sleep and Cognitive Peptides

DSIP is often mentioned alongside growth-hormone-releasing peptides and nootropics, even though they work through completely different pathways. If you are comparing options, it helps to know what each compound is actually studied for.

People who want to understand growth-hormone pathways often start by asking what is cjc 1295 peptide, while others look into what is ipamorelin peptide for a more selective GH secretagogue. Readers curious about focus and neuroprotection tend to search what is semax peptide used for. None of these peptides is interchangeable with DSIP, and stacking them is not supported by clinical evidence.

Is DSIP Legal in the United States?

DSIP is not approved by the FDA for human use in the United States. It is also not listed on the FDA's 503A bulk drug substances list, which means licensed compounding pharmacies cannot legally prepare it for patients.

DSIP is not a scheduled controlled substance under federal law, so simple possession is not automatically a crime. Even so, vendors typically sell it labeled "for research use only — not for human consumption," and importing it for personal human use can lead to shipment detention by customs.

Safety, Side Effects, and What to Do Instead

Reported side effects in early studies were generally mild and included nausea, headache, dizziness, daytime drowsiness, and occasional drops in blood pressure. Because those trials were small and short, long-term safety data in humans simply do not exist.

Research-grade peptides also carry purity risks. Third-party testing is not guaranteed, and an unverified vial may contain the wrong peptide, the wrong concentration, or bacterial contamination.

• If you have trouble sleeping, cognitive behavioral therapy for insomnia (CBT-I) is the first-line, evidence-based treatment.
• Talk with a healthcare professional before using any unapproved peptide, especially if you take blood pressure medication or sedatives.
• Avoid combining DSIP with alcohol, sleep aids, or other sedating substances.

DSIP remains an interesting research peptide with a striking name and thin human data. Treat marketing claims about it with caution, and treat sleep problems with a doctor rather than a vial.